Mindwalk Holdings Corp. balance sheet
At the end of fiscal 2026, Mindwalk Holdings Corp. had total assets of $15.7m, total liabilities of $7.1m and shareholders' equity of $8.6m. It held $8.4m in cash against $0 of debt: net cash of $8.4m.
Balance sheet
| Fiscal year | 2020Apr 2020 | 2021Apr 2021 | 2022Apr 2022 | 2023Apr 2023 | 2024Apr 2024 | 2025Apr 2025 | 2026Apr 2026 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2 | 34 | 23 | 6 | 3 | 8 | 8 |
| Inventory | 1 | 1 | 1 | 2 | 2 | 2 | 0 |
| Total current assets | 6 | 40 | 29 | 12 | 8 | 14 | 12 |
| Goodwill | 6 | 6 | 15 | 14 | 6 | 6 | 0 |
| Total assets | 20 | 54 | 73 | 57 | 44 | 32 | 16 |
| Total current liabilities | 6 | 5 | 7 | 4 | 6 | 7 | 4 |
| Total debt | 0 | — | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 9 | 8 | 14 | 15 | 18 | 15 | 7 |
| Shareholders' equity | 11 | 46 | 59 | 43 | 26 | 17 | 9 |
| Net debt (negative = net cash) | −2 | −34 | −23 | −6 | −3 | −8 | −8 |
| Shares outstanding | 14m | 19m | 24m | 25m | 27m | — | — |
Compare with peers
- Surrozen, Inc. balance sheet
- Relay Therapeutics, Inc. balance sheet
- Caribou Biosciences, Inc. balance sheet
- Opus Genetics, Inc. balance sheet
- Lineage Cell Therapeutics, Inc. balance sheet
Head to head: HYFT vs SRZNHYFT vs RLAYCRBU vs HYFTHYFT vs IRD
More: Biotechnology stocks compared, Health Care sector, rankings of US companies